ArticleTargeted oncology2018

Discovery of a Potent and Mutant-Selective EGFR Inhibitor that Overcomes T790M-Mediated Resistance in Lung Cancer.

Dong Ha Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.